Analysts Viewpoint
0 analysts rank AUPH stock as an Overweight
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or